Clinical Trials on Cirrose hepática

Total 1506 results

Daiichi Sankyo, Inc.
Medpace, Inc.

Completed

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Cancer | Solid Tumor | Hepatic Impairment

United States
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

Hepatic Insufficiency | Insomnia
Ono Pharma USA Inc
Ono Pharmaceutical Co. Ltd

Completed

An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic Impairment

Healthy | Hepatic Impairment

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Hepatic Insufficiency | Healthy

United States
Taipei Veterans General Hospital, Taiwan

Recruiting

Antibiotic Prophylaxis in Patients Undergoing GVO (ABX-GV)

Sepsis | Fever | Liver Cirrhoses | Gastric Varix

Taiwan
Alnylam Pharmaceuticals

Terminated

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Acute Hepatic Porphyria | Acute Intermittent Porphyria (AIP) | Hereditary Coproporphyria (HCP) | Variegate Porphyria (VP) | ALA Dehydratase Deficient Porphyria (ADP) | Hepatic Porphyrias | Porphyria Acute

United States
Al-Azhar University

Not yet recruiting

Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
National Hepatology & Tropical Medicine Research...

Not yet recruiting

Vegetable Proteins Versus Mixed Animal Proteins on the Outcome of Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
The Cleveland Clinic

Recruiting

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Massachusetts General Hospital
Center for Microbiome Informatics and Therapeutics

Active, not recruiting

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Bausch Health Americas, Inc.

Completed

A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy

Hepatic Encephalopathy
Bausch Health Americas, Inc.

Completed

Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Hepatic Encephalopathy

United States, Canada
Horizon Pharma Ireland, Ltd., Dublin Ireland

Terminated

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Hepatic Encephalopathy

United States
University of Aarhus

Unknown

Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy

Hepatic Encephalopathy

Denmark
Institute of Liver and Biliary Sciences, India

Completed

Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial

Hepatic Encephalopathy

India
Allegheny Singer Research Institute (also known...

Active, not recruiting

Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers

Liver Neoplasms | Hepatocellular Carcinoma | Liver Metastases | Liver Cancer | Liver Carcinoma | Hepatocellular Cancer | Hepatic Cirrhosis | Hepatic Carcinoma | Hepatic Atrophy

United States
MetroHealth Medical Center

Withdrawn

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

Cirrhosis, Liver | Small Intestinal Bacterial Overgrowth | Gastrointestinal Motility Disorder | Minimal Hepatic Encephalopathy

United States
Kirby Institute

Recruiting

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs (TOPIC)

Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Eli Lilly and Company

Recruiting

A Study of LY3502970 in Participants With Impaired and Normal Liver Function

Hepatic Insufficiency | Healthy

United States
Bristol-Myers Squibb

Recruiting

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Hepatic Insufficiency | Neoplasms

Spain, United States, Germany, Argentina, Colombia, Greece
Eli Lilly and Company
Loxo Oncology, Inc.

Completed

Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants

Hepatic Insufficiency | Healthy

United States
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

Hepatic Insufficiency | Healthy

Japan
Boehringer Ingelheim

Completed

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Hepatic Insufficiency | Healthy

Romania
Carol Davila University of Medicine and Pharmacy

Recruiting

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure (PASS)

Liver Failure | Cirrhosis, Liver | Ascites Hepatic

Romania
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Ain Shams University

Recruiting

Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
University Hospital, Toulouse
Société nationale française de gastro-entérologie

Recruiting

Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME) (POEME)

Hepatic Encephalopathy

France
Duke University

Recruiting

Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy

Hepatic Encephalopathy

United States
Mayo Clinic

Completed

Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration

Hepatic Encephalopathy

United States
University of Alberta
Rebiotix Inc.

Completed

Fecal Transplant for Hepatic Encephalopathy

Hepatic Encephalopathy

Canada
University of Alberta

Completed

Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study

Hepatic Encephalopathy

Canada
Mahidol University

Completed

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Thailand
Norgine

Completed

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) (PROSPER)

Hepatic Encephalopathy

United Kingdom
NYU Langone Health
Bausch Health Americas, Inc.

Terminated

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.

Hepatic Encephalopathy

United States
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (AST015)

Hepatic Encephalopathy

United States
Sanofi

Withdrawn

Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients (SECOX)

Hepatic Neoplasm Malignant
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function

Hepatic Insufficiency | Healthy Subjects

China
Baylor Research Institute

Completed

Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors

Liver Insufficiency

United States
Merck Sharp & Dohme LLC

Completed

A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

Liver Insufficiency
Zagazig University

Recruiting

The Role of Skin Microbiota in Hepatic or Renal Pruritus

Renal Failure | Pruritus | Hepatic Failure

Egypt
Bibo Wang
Eastern Hepatobiliary Surgery Hospital

Completed

Butorphanol in Pain Following Ablation for Hepatic Tumor

Visceral Pain | Hepatic Tumor | Microwave Ablation

China
Epizyme, Inc.
Sponsor GmbH

Recruiting

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Hepatic Impairment | Advanced Malignant Solid Tumor

France, Belgium, United States, Poland, Slovakia
Pfizer

Completed

A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

Hepatic Impairment | Healthy Participants

Czechia, Slovakia, Belgium
Institutul Clinic Fundeni

Completed

CytoSorb in Patients With Liver Failure

Liver Dysfunction

Romania
Seoul National University Hospital
Samsung Medison

Completed

Quantitative US for Hepatic Steatosis

Hepatic Steatosis

Korea, Republic of
Methodist Health System

Completed

Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy

Liver Diseases | Chronic Hepatic

United States
Pfizer

Completed

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Healthy Volunteers | Hepatic Impairment

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Hepatic Impairment

United States
Merck Sharp & Dohme LLC

Terminated

Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)

Hepatic Insufficiency | Antibacterial Agents

United States
Assistance Publique - Hôpitaux de Paris
Medical Innovation Developpement (MID)

Unknown

Pneumatic Reversible Portal Vein Diameter Modulation After Major Hepatectomy (MODHEP1)

Liver Failure | Major Hepatectomy

France

Clinical Trials on Cirrose hepática

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations